Takeda Pharmaceuticals shares were trading down more than 7% on Thursday, following the company’s initial public offering and the filing of a lawsuit.The stock’s price dropped nearly 25% from its high of $21.10 on Nov. 3.Takeda’s stock price has also been trending lower since the filing.The company reported a $1.8 billion loss in the first […]

Continue Reading...